Kawai Yoshiko, Taniuchi Saburo, Okahara Shigeki, Nakamura Masuhisa, Gemba Munekazu
Division of Pharmacology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.
Biol Pharm Bull. 2005 Aug;28(8):1385-8. doi: 10.1248/bpb.28.1385.
Nedaplatin is known to exhibit antitumor activity similar to that of cisplatin. However, concerning side effects, nedaplatin causes renal toxicity less frequently than cisplatin. In this study, we compared the incidence of renal toxicity between cisplatin and nedaplatin by investigating the difference in kidney tissue accumulation. Kidney tissue accumulation of cisplatin administered at 3.75 mg/kg was similar to that of nedaplatin administered at 24 mg/kg. At these doses, the plasma creatinine level and urinary excretion of glucose and N-acetyl-beta-D-glucosaminidase (NAG) similarly increased. There was a correlation between kidney accumulation of cisplatin and nedaplatin and the increases in plasma creatinine level and urinary excretion of NAG. Therefore, our results suggest that nedaplatin less frequently causes renal toxicity in comparison to cisplatin due to lower kidney accumulation.
已知奈达铂具有与顺铂相似的抗肿瘤活性。然而,在副作用方面,奈达铂引起肾毒性的频率低于顺铂。在本研究中,我们通过研究肾脏组织蓄积的差异,比较了顺铂和奈达铂之间肾毒性的发生率。以3.75mg/kg剂量给药的顺铂在肾脏组织中的蓄积与以24mg/kg剂量给药的奈达铂相似。在这些剂量下,血浆肌酐水平以及葡萄糖和N-乙酰-β-D-氨基葡萄糖苷酶(NAG)的尿排泄量同样增加。顺铂和奈达铂在肾脏中的蓄积与血浆肌酐水平的升高以及NAG的尿排泄量之间存在相关性。因此,我们的结果表明,与顺铂相比,奈达铂引起肾毒性的频率较低,这是由于其在肾脏中的蓄积较低。